Angola vs Niger: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Angola
3.1%
in 2024
Niger
3.2%
in 2024
Angola rank
5th
Niger rank
3rd
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Angola
- Niger
How they compare
Niger currently reports 3.2% against 3.1% in Angola, a difference of 0.1%.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Angola ahead.
Angola ranks 5th and Niger ranks 3rd of 215 countries.
Niger has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Angola | Niger | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.6% | 2.6% | 0.0% | — |
| 2020s | 3.0% | 3.4% | 0.4% | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Angola or Niger?
- Niger, at 3.2% against 3.1% in Angola as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Angola and Niger?
- 0.1%, with Niger ahead.
- How many years of comparable data are there for Angola and Niger?
- 10 years are reported by both, from 2015 to 2024.
- How do Angola and Niger rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Angola ranks 5th and Niger ranks 3rd of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.